Rate of Postpyloric Migration of Spiral Nasojejunal Tubes in Brain Injured Patients
NCT ID: NCT00562146
Last Updated: 2008-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2007-12-31
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are several methods to place postpyloric tube, but there is a high success rate with endoscopic or radiological assistance. However, they are time consuming procedures, which is of limited availability at bedside and requires trained staff.
Nasojejunal tube with spiral end (Flocare Bengmark NJ tube) has been used for bedside placement for 10 years. But only limited data are available for success rate, especially in brain injured patients. The aim of this study is to access the success rate and influencing factors of spiral end nasojejunal tube in such a population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Successful progression of spiral tube to duodenum within 3 days
placement of spiral nasojejunal tube
spiral nasojejunal tube will be placed after enrollment of the patients
2
Failure of progression to duodenum within 3 days
placement of spiral nasojejunal tube
spiral nasojejunal tube will be placed after enrollment of the patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
placement of spiral nasojejunal tube
spiral nasojejunal tube will be placed after enrollment of the patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with contraindication to naso-feeding tube placement
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ICU, Beijing Tiantan Hospital, Capital Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jian-Xin Zhou, MD
Role: STUDY_CHAIR
ICU, Beijing Tiantan Hospital, Capital Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ICU, Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BJTTH-ICU-07-011
Identifier Type: -
Identifier Source: secondary_id
BJTTH-ICU-07-011
Identifier Type: -
Identifier Source: org_study_id